The Feed Research Institute of Chinese Academy of Agricultural Sciences and Beijing Shougang Lang Ze New Energy Technology Co., Ltd. jointly announced that, after years of joint research, the one-step synthesis of protein from carbon monoxide was realized for the first time in the world, and an industrial capacity of 10,000 tons was formed. This move broke through the time and space limitation of natural protein plant synthesis. Under the background that the foreign dependence of feed protein raw materials in China has remained above 80% for a long time, and the highest year of soybean import exceeded 654.38+billion tons, it has far-reaching significance for making up for the shortcomings of China's agriculture and promoting the national goal of "double carbon".
According to relevant institutions, synthetic biology is a future-oriented industry and an important cornerstone for achieving sustainable development and carbon neutrality. Although synthetic biology currently accounts for a small proportion in the total production scale, it has entered a period of rapid development and may even subvert many existing industries in the future, which is very worthy of attention. McKinsey believes that 60% of the products in the world can be produced by biological methods. In the next 10-20 years, it is estimated that the market of synthetic organisms related to materials, chemicals and energy will have a space of 200-300 billion US dollars.
In China, the well-known synthetic biology listed company is Kaisai Bio. The company's 40,000-ton biological sebacic acid (DC 10) project has started in Kaisai Taiyuan production base, and sebacic acid can be used as polymerization monomer to produce long-chain nylon, sebacic acid ester and other products. Sebacic acid is about 1 10000 tons in the world. In the past, it was mainly prepared by hydrolysis and cracking of castor oil, and it is expected to be replaced by Kaiser's biological method in the future.
Kaisai Bio was founded in 2000, and it is already an established company in terms of its development years. In fact, Kaisai Bio promoted the IPO to the United States as early as 20 1 1, but it finally failed due to various factors. Finally listed on China Science and Technology Innovation Board!
At present, the main income source of Kaisai Bio is its series products of "biological long-chain dibasic acids". During the reporting period, these products accounted for 99.62%, 99.70% and 99.56% of the main business income respectively, reaching 177 1 billion yuan in 20 19 years.
Polyamide can be obtained by polymerization of diacid and diamine, which can be used as synthetic raw materials such as perfume, hot melt adhesive, lubricating oil and coating. Therefore, Kaisai Bio-plans to produce bio-long-chain diacid series, bio-pentanediamine and bio-polyamide products around the polyamide industrial chain, which is expected to be widely used in the fields of automobiles, electronic appliances, textiles, medicine, spices and so on.
Based on the above information, we can see that this is a very promising field. I hope this article can help you!